P Pu ur rp po os se e: : To determine whether the use of cell salvage reduces the proportion of patients receiving at least one unit of allogeneic packed red blood cells during the perioperative period of an elective vascular surgery.
S So ou ur rc ce e: : We identified all relevant articles through the combined use of electronic searches of the MEDLINE and EMBASE databases, the Cochrane library as well as hand searching of all randomized clinical trials and review articles. The electronic search included articles published between 1966 and April 2001. The search included textword searches using "autotransfusion," "cell salvage," "device," or Medical Subject Headings "autologous blood transfusion" or a "randomized controlled trials" filter.
P Pr ri in nc ci ip pa al l f fi in nd di in ng gs s: : Five randomized controlled trials (RCT) were identified involving cell salvage and vascular surgeries. In infra renal abdominal aortic aneurysm surgery the risk ratio (the risk of receiving at least one unit of allogeneic red cells) was 0.37 [95% confidence intervals (CI) of 0.06 to 2.36]. In elective aorto-femoral bypass surgery the risk ratio was 0.97 (95% CI of 0.66 to 1.42). The pooled risk ratio for cell salvage in vascular surgery was 0.67 (95% CI of 0.35 to 1.28).
C Co on nc cl lu us si io on n: : Cell salvage, a commonly used technique to recover red cells from the operative field, has been the subject of several studies in vascular surgery. There is insufficient evidence to recommend the routine use of cell salvage in elective abdominal aortic aneurysm and aorto-femoral bypass surgeries. A large RCT would elucidate whether cell salvage is effective as a blood conservation technique. HE medical community has been investigating new approaches aimed at reducing the amount of allogeneic blood transfused in the perioperative period for several decades. Recently, the impetus to avoid blood transfusions has been based upon the many adverse consequences including the transmission of transfusion-related viral infections such as hepatitis B and C as well as the human immunodeficiency virus. [1] [2] [3] [4] [5] [6] Cell salvage is a blood conservation technique developed and adopted in the past 20 years as a means of decreasing blood transfusions. The technique recovers blood lost in the operative field, purifies it and returns the recovered red blood cells (RBCs) to the patient thereby potentially avoiding exposure to blood products. Many hospitals have included cell salvage as part of the procedures made available to surgical teams that undertake interventions with large anticipated blood losses. 7 The cell salvage technique is widely used in orthopedic surgery where evidence suggested a reduction in exposure to blood products, however a similar benefit was not observed in cardiac surgery. 7 In vascular surgery, there are many published studies that support the use of cell salvage. However, a significant proportion of these studies make use of historical controls or are observational in nature. In addition, the results of a recent randomized controlled trial 8 did not observe any decrease in red cell transfusions using cell salvage. The authors concluded that this technique should no longer be considered standard of care. Given genuine uncertainty regarding the use of cell salvage in vascular surgery, we conducted a systematic review of published studies to determine if cell salvage reduced the exposure of red cells.
Objectif

M Me et th ho od ds s Identification and selection of studies
In this systematic review, we identified all relevant articles through the combined use of electronic searches of the MEDLINE and EMBASE databases, the Cochrane library as well as hand searching of all randomized clinical trials and review articles. The electronic search included articles published between 1966 and April 2001. The search included textword searches using "autotransfusion," "cell salvage," "device," or Medical Subject Headings "autologous blood transfusion" or a "randomized controlled trials" filter.
We selected studies that met the following criteria. The article was required to state that the study: 1) used a form of random allocation; 2) incorporated a control group that did not receive blood products recovered from a cell salvage device; 3) enrolled patients who underwent an elective abdominal vascular surgery (infra renal abdominal aortic aneurysm or a aorto-bifemoral bypass); and 4) reported the proportion of patients receiving at least one unit of allogeneic blood (the primary outcome). Studies were excluded from the meta-analysis if: 1) they were duplicate publications; 2) primarily involved patients under the age of 18 yr; and 3) allocated patients in the postoperative period.
One of the investigators (G.A.) examined all titles and abstracts obtained in these searches to determine eligibility of the randomized trial in this review. References of retrieved articles were also identified and examined to find additional studies. All randomized controlled trials identified were critically appraised.
Data extraction and synthesis
Once identified, the abstracted data included the proportion of patients receiving at least one unit of allogeneic packed RBCs as a primary outcome. We also gathered data on the mean number of RBC units transfused, 9 the number of patients receiving autologous predonation, the quantity of red cells transfused in millilitres as well as clinical outcomes including complication from surgery and mortality rates. Information related to cell salvage technique included the model of the cell saver, the type of blood collection (washed vs unwashed) and the length of time of cell saver use. Other pertinent information related to the study itself included baseline demographics, exclusion criteria, as well as the number of study participants enrolled in the trial. Finally, we assessed indicators of the quality of the studies, specifically blinding, method of randomization and the completeness of follow-up once randomized.
The effect of cell salvage on the proportion of patients who received allogeneic blood was summarized with an overall estimate of the relative risk (RR) and 95% confidence intervals (CI) by using a Mantel and Haenszel's fixed-effects model. 10 In this report, a RR with 95% CI incorporating 1.0 suggests that there is no difference between groups or insufficient data to conclude that cell salvage decreased overall exposure to red cells. A RR with a point estimate and 95% CI less than 1.0 suggests that fewer patients in the cell salvage group received at least one unit of allogeneic red cells while a RR greater than 1.0 suggests that more patients in the cell salvage group received at least one red cell transfusion. The electronic literature searches done in this study yielded 120 citations from the MEDLINE database and 117 citations from the EMBASE database. Five randomized controlled trials compared cell salvage to control in abdominal vascular surgical procedures. 8, [11] [12] [13] [14] Two additional trials were excluded because allocation did not make use of randomization but rather alternately assigned patients to either cell salvage or no cell salvage. 11, 14 The three remaining trials, made use of sealed opaque envelopes as a means of concealment of randomization. 8, 12, 13 None of these studies made use of blinding. It would have been technically difficult if not impossible to mask cell salvage from the anesthesiologist and surgeon. Of these three randomized trials, one involved both elective infra renal abdominal aortic aneurysm surgery and aortofemoral bypass surgery, the second was only elective infra renal abdominal aortic aneurysm surgery and the third was only aorto-femoral bypass surgery (Table I) .
The combined or pooled risk ratio for a decreased exposure to red cells with cell salvage in infra renal aortic aneurysm repair and aorto-femoral bypass was 0.67 (95% CI from 0.35 to 1.28). Only two of the four randomized controlled trials involving elective infra renal aortic abdominal aneurysm repair met the inclusion criteria. The study from Thompson and colleagues 14 could not be evaluated since it did not report the proportion of patients who were transfused red cells. In addition, details regarding the surgical procedures and the use of cell salvage were not reported. Similarly, Varga et al. 11 did not report the proportion of patients transfused. The two remaining studies met all inclusion criteria. 8, 13 Clagett and colleagues 8 demonstrated that cell salvage did not reduce the proportion of patients exposed to allogeneic blood (RR = 0.89, 95% CI from 0.63 to 1.27). Results reported by Spark and colleagues 13 were in the opposite direction. The investigators observed a significant decrease in exposure to red cells favouring cell salvage (RR = 0.14, 95% CI from 0.05 to 0.39). The combined risk ratio for cell salvage in infra renal abdominal aortic aneurysm surgery was 0.37 (95% CI from 0.06 to 2.36). There were insufficient data extracted from the two publications to compare differences between mean units transfused.
We identified two randomized controlled trials in patients undergoing elective aorto-femoral bypass surgery. 8, 12 Neither study demonstrated a clinically important decrease in the number of patients exposed to red cells following the use of cell salvage. The Clagett study reported a RR of 0.94 (95% CI from 0.63 to 1.40) and the Kelley-Patteson study reported a RR of 1.50 (95% CI from 0.28 to 7.93). The pooled RR was 0.97 (95% CI from 0.66 to 1.42). There were insufficient data from both studies to compare and analyze the differences between mean units transfused.
D Di is sc cu us ss si io on n In this meta-analysis of randomized controlled trials, we were unable to demonstrate that cell salvage decreased exposure to allogeneic red cell cells. Our AAA = abdominal aortic aneurysm; AFB = aorto-bi-femoral bypass; CS = cell saver. All cell saver units were washed. *The Clagett group studied both AAA and AFB concurrently. inability to detect a clinically important benefit may be because the technique is truly ineffective or as a consequence of the few patients in small studies included in this review. The few small trials generated a combined RR of 0.35 with large 95% confidence boundaries ranging from 0.35 to 1.28. Similarly, there were too few data to determine whether cell salvage decreased the mean number of RBC units transfused during abdominal aortic surgical procedures. In the subgroup of patients who underwent infra renal abdominal aortic aneurysm surgery, the pooled RR for cell salvage was 0.37 with 95% CI ranging from 0.06 to 2.36. In this instance, the very large CIs were primarily a function of divergent study results. In addition to the limited information available for review, there were a number of clinical and methodological differences between the trials. These differences may also offer plausible explanations for our inability to observe benefits from this blood conservation technique. Key differences between studies included referral patterns that may have caused differences in surgical complexity and severity of illness, surgical technique, cell salvage techniques, the type and frequency of complications, approach to randomization as well as other factors.
In the Clagett study, the greater use of re-transfused salvaged red cells was associated with an increased use of allogeneic blood required to maintain comparable hemoglobin concentrations. In an accompanying editorial, Ouriel noted that despite two additional red cell units recovered from the cell salvage procedure, postoperative hematocrit levels were com- parable between groups immediately following surgery. 8 One would have expected a measurable increase in red cell mass given that patients received extra salvaged red cells. A plausible explanation for the inability to detect a rise in postoperative hemoglobin concentrations elaborated in the editorial was excess hemolysis of salvaged red cells in study participants. Unfortunately, markers of hemolysis were not measured by Clagett and colleagues. Other potential explanations may include differences in fluid administration resulting in dilutional anemia in the postoperative period.
Hemolysis from cell salvage procedures may occur because of suction pressures in the collection of shed red cells that increase shear stress in the plastic tubing and filters in the device, as well as the centrifugation process. 15 In their trial Spark and colleagues standardized the suction pressures not to exceed 150 mmHg and filter sizes used during surgery. As a consequence, they did not observe significant differences in biochemical and morphological markers of hemolysis. Differences in the type of device may also have caused different rates of clinically important hemolysis observed in the two trials.
The marked difference in reported cross clamp time and the length of time required for the operative intervention may indicate differences in the selection of study participants or surgical techniques. Indeed, reported results from the Clagett trial averaged almost twice the amount of time patients were anesthetized, doubled the length of time of cross clamp and operation time when compared to Spark et al. (Table II ). The longer cross-clamp times 16 or the re-infusion of hemolyzed red cells may have resulted in an increased rate of complications such as nosocomial infections, lengths of stay and perioperative mortality. Unfortunately, both studies were not large enough to detect changes in most clinically important outcomes.
Although both major trials used random allocation, the cell salvage group may well have been healthier than the control group in the study reported by Clagett. The control group had almost twice as many patients with chronic obstructive pulmonary disease (14% vs 26%) and three times as many patients with chronic renal failure patients (8% vs 22%). Both major co-morbidities may have increased the rates of transfusion in the control group thereby potentially resulting in a bias favouring cell salvage. Indeed there were twice as many "unusual bleeding" episodes in the control group as compared to the cell salvage group (46% vs 20%). These results are consistent with sicker patients being enrolled in the control group.
The randomized trials also included patients undergoing aorto-femoral bypass surgery. 8, 12 This surgical intervention requires significantly less RBC transfusions as compared to aortic aneurysm surgery. Both major studies 8, 12 evaluating cell salvage during aortofemoral bypass were not able to document any savings in allogeneic RBC use with this technique. Inferences from these studies and the resultant meta-analysis are weak given the small sample size of both individual studies and the pooled results. The use of cell salvage for surgical procedures with low blood loss such as aorto-femoral bypass will likely not reduce or eliminate exposure to allogeneic RBCs.
Although only three randomized controlled trials met inclusion criteria, each study adequately described the study population, the cell salvage techniques and their complications, the transfusion protocols as well as important surgical and anesthetic benchmarks. In addition, the reports adequately described the use of standard concealment of randomization technique, reported on all major objective outcomes and major co-interventions. The reporting of outcomes and cointerventions is all the more important in studies where blinding is not possible.
In conclusion, the results of this meta-analysis did not find sufficient evidence that cell salvage decreases exposure to allogeneic red cells in abdominal vascular surgeries. Unfortunately, there are too few studies involving too few patients to draw inferences regarding the benefit of therapy. Indeed, the fact that three randomized controlled trials documented divergent outcomes underscores the need for further research. In addition, we identified even fewer data examining the consequences of this blood sparing technique on clinically important outcomes such as infections, organ failure and mortality. Given the substantial cost associated with this technique, we believe that it is all the more important to conduct a large randomized controlled trial in this patient population.
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